GAL-1C BLOOD GLUCOSE MONITORING SYSTEM, GAL-1C TEST STRIPS— 510(k) K102816

Substantially Equivalent

Apex BioTechnology Corp.

FDA 510(k) clearance K102816 for GAL-1C BLOOD GLUCOSE MONITORING SYSTEM, GAL-1C TEST STRIPS, Substantially Equivalent on 2011-09-15. Applicant: Apex BioTechnology Corp..

Clearance details

Applicant: Apex BioTechnology Corp.
Product code: Code NBW
Advisory panel: Clinical Chemistry
Date received: 2010-09-28
Decision date: 2011-09-15
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Hsinchu, TW

Download summary PDF View on FDA.gov ↗

Adverse events under product code NBW

product code NBW

Death: 18
Injury: 4,740
Malfunction: 42,679
Other: 6
Total: 47,443

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.